Cover Image

Safety and Therapeutic Optimization of Lutetium-177 Based Radiopharmaceuticals

Peptide receptor radionuclide therapy (PRRT) using Lutetium-177 (<sup>177</sup>Lu) based radiopharmaceuticals has emerged as a therapeutic area in the field of nuclear medicine and oncology, allowing for personalized medicine. Since the first market authorization in 2018 of [¹⁷⁷Lu]Lu-DOT...

Full description

Saved in:

Bibliographic Details
Main Authors:	Typhanie Ladrière (Author), Julie Faudemer (Author), Elise Levigoureux (Author), Damien Peyronnet (Author), Cédric Desmonts (Author), Jonathan Vigne (Author)
Format:	Book
Published:	MDPI AG, 2023-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative Radioimmunotherapy of Experimental Melanoma with Novel Humanized Antibody to Melanin Labeled with 213Bismuth and 177Lutetium
by: Kevin J. H. Allen, et al.
Published: (2019)

How to validate radiopharmaceuticals management software?
by: Léa De Neef, et al.
Published: (2020)

Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer
by: Rien Ritawidya, et al.
Published: (2023)

Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [177Lu]Lu-PSMA
by: Eline L. Hooijman, et al.
Published: (2022)

Evaluation of the 177mLu-concentration in in-house produced 177Lu-radiopharmaceuticals and commercially available Lutathera®
by: Matthias Balzer, et al.
Published: (2023)

Synthesis, Radiolabelling and In Vitro Characterization of the Gallium-68-, Yttrium-90- and Lutetium-177-Labelled PSMA Ligand, CHX-A''-DTPA-DUPA-Pep
by: Benjamin Baur, et al.
Published: (2014)

Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy
by: Cyprine Neba Funeh, et al.
Published: (2023)

A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma-LuDO-N
by: Fredrik Sundquist, et al.
Published: (2022)

Synthesis, Physicochemical and Biological Study of Gallium-68- and Lutetium-177-Labeled VEGF-A<sub>165</sub>/NRP-1 Complex Inhibitors Based on Peptide A7R and Branched Peptidomimetic
by: Katarzyna Masłowska, et al.
Published: (2022)

The development of 177Lu-DOTA-CC-PSMA following a unified "Click Chemistry" protocol of synthesizing metal nuclide-conjugated radiopharmaceuticals
by: Xiaobei Zheng, et al.
Published: (2024)

Radionuclide generator-based production of therapeutic 177Lu from its long-lived isomer 177mLu
by: Rupali Bhardwaj, et al.
Published: (2019)

Optimized Therapeutic <sup>177</sup>Lu-Labeled PSMA-Targeted Ligands with Improved Pharmacokinetic Characteristics for Prostate Cancer
by: Yitian Wu, et al.
Published: (2022)

Investigation of the Effect on the Albumin Binding Moiety for the Pharmacokinetic Properties of <sup>68</sup>Ga-, <sup>205/206</sup>Bi-, and <sup>177</sup>Lu-Labeled NAPamide-Based Radiopharmaceuticals
by: Dániel Szücs, et al.
Published: (2023)

Optimization Processes of Clinical Chelation-Based Radiopharmaceuticals for Pathway-Directed Targeted Radionuclide Therapy in Oncology
by: Katsumi Tomiyoshi, et al.
Published: (2024)

Financial Toxicity Encountered in Therapeutic Radiopharmaceutical Clinical Development for Ovarian Cancer
by: Charles A. Kunos, et al.
Published: (2020)

Optimization of 177Lu-labelling of DOTA-TOC, PSMA-I&T and FAPI-46 for clinical application
by: Aylin Cankaya, et al.
Published: (2023)

Radiopharmaceuticals Current Research for Better Diagnosis and Therapy
Published: (2022)

Are we "preparing" radiopharmaceuticals?
by: Clemens Decristoforo, et al.
Published: (2016)

Metal-Based Radiopharmaceuticals in Inorganic Chemistry
Published: (2023)

Prospects for Radiopharmaceuticals as Effective and Safe Therapeutics in Oncology and Challenges of Tumor Resistance to Radiotherapy
by: Ekaterina Nikolova, et al.
Published: (2021)

Therapeutic Efficacy of <sup>177</sup>Lu-Labeled A20FMDV2 Peptides Targeting α<sub>ν</sub>β<sub>6</sub>
by: Truc Thao Huynh, et al.
Published: (2022)

Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
by: Liesbeth Everix, et al.
Published: (2023)

Current Aspects of Radiopharmaceutical Chemistry
by: Peter Brust (Ed.)
Published: (2018)

Innovative Radiopharmaceuticals in Oncology and Neurology
by: Michel Cherel
Published: (2017)

Radiopharmaceuticals for Treatment of Adrenocortical Carcinoma
by: Kerstin Michalski, et al.
Published: (2023)

Radiopharmaceuticals for Cancer Imaging and Therapy
by: Guy Bormans, et al.
Published: (2023)

Intra-Arterial Delivery of Radiopharmaceuticals in Oncology: Current Trends and the Future of Alpha-Particle Therapeutics
by: Nathan Kauffman, et al.
Published: (2023)

Radiopharmaceutical Chemistry between Imaging and Endoradiotherapy Radiopharmaceutical Chemistry between Imaging and Radioendotherapy
Published: (2015)

Synthesis, Characterization, and Therapeutic Efficacy of <sup>177</sup>Lu-DMSA@SPIONs in Nanobrachytherapy of Solid Tumors
by: Dragana Stanković, et al.
Published: (2023)

Increase expression of CD177 in Kawasaki disease
by: Ying-Hsien Huang, et al.
Published: (2019)

Errata: 2011;45(3):176-177.
by: Mirko Prosen, et al.
Published: (2011)

Liquid Chromatography ICP-MS to Assess the Stability of <sup>175</sup>Lu- and <sup>nat</sup>Ga-Based Tumor-Targeting Agents towards the Development of <sup>177</sup>Lu- and <sup>68</sup>Ga-Labeled Radiopharmaceuticals
by: Rahel H. Wallimann, et al.
Published: (2024)

EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging quality
by: Gert Luurtsema, et al.
Published: (2021)

Radiopharmaceuticals for PET Imaging - Issue A
Published: (2020)

Fundamental concepts of radiopharmaceuticals quality controls
by: Sajjad Molavipordanjani, et al.
Published: (2018)

US and EU radiopharmaceutical diagnostic and therapeutic nonclinical study requirements for clinical trials authorizations and marketing authorizations
by: Sally W. Schwarz, et al.
Published: (2019)

Radiopharmaceutical Labelling for Lung Ventilation/Perfusion PET/CT Imaging: A Review of Production and Optimization Processes for Clinical Use
by: Frédérique Blanc-Béguin, et al.
Published: (2022)

Recently developed radiopharmaceuticals for bacterial infection imaging
by: Maryke Kahts, et al.
Published: (2024)

Good practices for 68Ga radiopharmaceutical production
by: Bryce J. B. Nelson, et al.
Published: (2022)

Production and separation of 43Sc for radiopharmaceutical purposes
by: Katharina A. Domnanich, et al.
Published: (2017)